Itolizumab
Itolizumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Itolizumab is under investigation in clinical trial NCT04605926 (A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19).
| Trade Name | Itolizumab |
| Generic | Itolizumab |
| Itolizumab Other Names | Itolizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
How Itolizumab works
Itolizumab binds to CD6 which modulates T-lymphocyte activation and proliferation. It is an efficacious immunomodulatory compound investigated for treating psoriasis. Currently, the full mechanisms of action are still unclear.
Innovators Monograph
You find simplified version here Itolizumab
